AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's ...
Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its ...
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...
GlobalData on MSN7h
Pfizer wins cancer drug patent case against AstraZeneca"Pfizer wins cancer drug patent case against AstraZeneca" was originally created and published by Pharmaceutical Technology, ...
A Delaware federal jury has ordered AstraZeneca to fork over $107.5 million to Pfizer for infringing two of the latter ...
Pfizer’s Wyeth unit notched a legal victory over AstraZenca on Friday as a federal jury found the British-Swedish company ...
Pfizer has efficiently cut costs down to boost guidance. Read why PFE stock is a great option for dividend growth-focused ...
Pfizer has been a losing investment for several years, but stronger trading momentum is starting to appear. See why I ...
The Cambridge biotech said Friday that the European Patent Office has upheld the validity of one of its key patents, a ...
This week’s Historical Treasure is a CLIN-BYLA Pfizer medal that depicts a colony of the bacterium Streptomyces Rimosus on ...
A Delaware, USA, federal jury on Friday said that AstraZeneca should pay $107.5 million in royalty damages for infringing a Pfizer-brand cancer treatment patent, with its cancer drug Tagrisso ...
Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results